Experts have warned about the use of talcum powder for years, but these claims have been a source of controversy. Researchers have recently put that controversy to rest by publishing the results of a study linking talcum powder to uterine cancer.
Researchers at Brigham and Women’s Hospital found that using talcum powder in the genital area can lead to a higher risk of ovarian cancer in women. In fact, this cancer risk was shown to be about one-third higher in those who use talcum powder. Scientists who participated in this study are calling for manufacturers to place labels on talcum powder products so women who use them are informed of these risks. Talcum powder is believed to raise the risk of ovarian cancer if it gets into the vagina and reaches the upper genital tract.
This study was published shortly after a jury ordered manufacturer Johnson & Johnson to pay the family of a woman who died of uterine cancer $72 million. The family claims that the woman’s use of Johnson & Johnson’s talcum powder products led to her developing this deadly form of cancer.
The Brigham and Women’s Hospital study provides further evidence that there is a link between the use of talcum powder and an increased risk of ovarian cancer. While scientists state that more research is needed, many caution against using this type of powder, especially in the genital area.
Aspirin use has been recommended for those who have higher risks of cardiovascular disease, but can it help prevent colon cancer as well? A panel of medical experts at the U.S. Preventive Services Task Force recently issued guidelines that do recommend aspirin therapy for cancer in those with a higher risk of developing colorectal cancer.
Taking low-dose aspirin on a daily basis has been shown to decrease the risk of developing colorectal cancer in those who are over 50 years old. Medical experts at USPSTF carefully considered the risks of daily aspirin use along with these health benefits in order to determine whether or not to recommend it for those with a higher risk of colorectal cancer.
The recently issued guidelines state that adults who are 50 years old or older should take aspirin daily if they have higher risks of getting this type of cancer and higher risks of stroke and heart disease. However, experts caution that taking aspirin on a regular basis is not considered safe for those with certain health issues, such as risk factors for stomach bleeding. Aspirin can increase the risk of stomach bleeding, so it’s important for those who take it to only have low doses of it each day.
Those who are considering taking low-dose aspirin therapy for cancer should talk to their doctor first to make sure it’s safe for them to do so. This helps lower the risk of side effects or adverse reactions.
Issels® offers immunotherapy for those who want advanced non-toxic forms of treatment for cancer. Contact us to learn more about these treatments.
Could information technology be part of the solution to curing breast cancer? Researchers and healthcare specialists are about to find out as genetic profiles of thousands of cancer patients have been released to the public.
Big data meets cancer research
Results of genomic testing are normally kept confidential and stored within a patient’s file. Early this past March, Ambry Genetics made the contents of their AmbryShare database publicly available at no charge.
The database contains anonymous data obtained from testing of the company’s thousands of breast and ovarian cancer patients. Doctors, researchers and other patients can now access this information in search of genetic patterns.
“Delaying medical progress”
Amber Genetics CEO and founder Charles Dunlop, himself a stage four cancer survivor, issued a statement in conjunction with the data release. In it, he expressed shock that public and private laboratories would withhold such information at the cost of “delaying medical progress” that could end the suffering of other cancer patients.
Not everyone is optimistic about this development. Genetics professor David B. Goldstein of Columbia University told the New York Times he was unsure that this database is enough to make a difference. But one important believer is President Barack Obama, whose administration’s “Precision Medicine Initiative” is working on establishing a database containing genetic and long-term health information for one million Americans.
Genomic testing at Issels®
Genomic testing is just one of the methods we use to develop our non-toxic integrative treatments. Visit our website to view testimonials from patients with breast cancer, leukemia, melanoma and other forms of cancer which have been successfully treated at our immuno-oncology centers.
As recently as 15 years ago, the chances of survival for a patient whose melanoma had spread to other parts of the body were only slightly more than zero. Today, thanks to advancements in the area of integrative immunotherapy, these patients have a legitimate source of hope.
Paving the way for treatment
Pete Daly was one of those patients for whom a diagnosis of metastatic melanoma meant a bleak future. With immunotherapy entering a clinical trial phase, Daly believed his participation would give meaning to his situation by helping others.
Up to that point, testing had been done only on monkeys. It didn’t take long to see results as within weeks Daly’s doctors found that his tumors were shrinking. Currently, 13 years after testing Daly continues to show no signs of cancer.
Former President Jimmy Carter is another patient who has benefited from integrative immunotherapy. He is also no longer showing signs of the melanoma that had formed in his liver and brain.
Immunotherapy is a “game changer”
Oncologist Dr. Mark Albertini of the Carbone Cancer Center at University of Wisconsin Health credits the courage of patients like Daly for contributing to the development of immunotherapy treatments, which he refers to as “game changers.” Dr. Albertini stresses that early detection is still key to successful cancer treatment.
Issels® has been a pioneer in the use of integrative immunotherapy treatments that are personalized to meet each patient’s individual needs. Visit our website today to learn more about our cancer vaccines and other advanced non-toxic cancer treatment protocols.
One of the major road blocks in cancer research has been the unchecked mutations undergone by cancer cells, creating a moving target. An international team recently made a discovery that could overcome the problem, leading to a breakthrough for integrative immunotherapy methods.
Targeting the “tree trunk”
The group of researchers found that, in addition to random mutations, cancer cells within an individual also share specific mutations that can be isolated and attacked. Dr. Sergio Quezada of University College London’s Cancer Institute, co-author of the study, likened the approach to killing a “tree trunk” rather than fighting a tangle of branches.
Creating customized treatment
Dr. Quezeda went on to explain that a customized vaccine could be developed to attack the core mutations in a particular patient. Another possibility would be discovering which T-cells produced by the immune system fight the specific mutations. Those T-cells would then be “fished” from the patient, multiplied in a lab, and re-injected into the body.
What’s in the future?
According to Dr. Quezeda, he believes these specialized treatments would be most effective against melanoma and lung cancer. Both are on the list of the 10 most common forms of cancer in the United States. Dr. Quezeda is hopeful that, in light of this study, trials will begin within five years.
Our Issels® integrative immunotherapy centers have long been in the forefront of using personalized treatment protocols. Each patient receives a specifically created program based on genetic predisposition, lifestyle, environment and other individual factors. Visit our website to read and watch testimonials from patients who have been successfully treated at the Issels® treatment centers.
Whether patients undergo traditional or alternative cancer treatments, there may come a time when further care requires a stay in the hospital. Even though the patients are surrounded by doctors, nurses and other healthcare providers, they benefit from continued support from their personal caregivers.
Actively participate in the patient’s health care team. As a close friend or family member, you can provide valuable information to assist the medical professionals in deciding on the proper care.
Establish a relationship with the patient’s nurses. They are on the front lines of patient care, and they can help you understand treatments and procedures while offering support and information.
Consult with a hospital social worker or case manager. They can help you stay on top of administrative details such as insurance matters, coordination of care between specialists and support resources.
Develop an organized information management system. The patient relies on you to handle tasks like filling prescriptions, scheduling appointments and contacting family and friends. Develop a simple method to keep documents and other necessary information organized and easily accessible.
Alternative cancer treatments at Issels® are available on either an outpatient or inpatient basis. If you or a loved one is dealing with cancer, contact us today for more information about our personalized protocols such as vaccines and immunotherapy for cancer treatment.